Hanno Hock is an Oncology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 84 publications with 6,316 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit Street
Hematology Oncology Yaw 7b
Boston, MA 02114
Telephone
617-724-4000Registry record last updated 11 Sept 2025.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
54.5%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor54.5%Acyclovir100%Part D<11 patientsCancer & immunology
23.6%BCR-ABL tyrosine kinase inhibitors23.6%Scemblix100%Part D<11 patientsSensory organs
21.8%Corticosteroid21.8%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Interrogating the role of H3K4 & H3K27 methylation in hematopoiesis with novel histone tools
Massachusetts General Hospital
FY2026$761,577R01DK145735 - Function of zinc-finger transcription factor Gfi-1 in hematopoietic stem cells
Massachusetts General Hospital
FY2011$304,832R01CA122726 - Function of zinc-finger transcription factor Gfi-1 in hematopoietic stem cells
Massachusetts General Hospital
FY2010$314,260R01CA122726
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”